Effect of polyethylene glycol-lipid derivatives on the stability of grafted liposomes

Yaoxue Xuebao

Volumn 46, Issue 10, 2011, Pages 1178-1186

  Xu, Yang ^a   Shi, Li ^b   Deng, Yi Hui ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b Liaoning Institute of Pharmaceutical Industry   (China)

Author keywords

Liposome; PEG lipid derivative; Stability

Indexed keywords

AMIDE; CHOLESTEROL; DIACYLGLYCEROL; DISULFIDE; ESTER; ETHER; GLYCOLIPID; LIPOSOME; MACROGOL DERIVATIVE; PHOSPHATIDYLETHANOLAMINE;

CHEMICAL STRUCTURE; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR STABILITY; MOLECULAR WEIGHT; PLASMA CLEARANCE; REVIEW;

CHOLESTEROL; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FATTY ACIDS; LIPOSOMES; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS;

EID: 83455258066     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Klausner RD, Blumenthal R, Innerarity T, et al. The interaction of apolipoprotein A-I with small unilamellar vesicles of L-alpha- dipalmitoylphosphatidylcholine [J]. J Biol Chem, 1985, 260: 13719-13727. (Pubitemid 16233227)
2. Muller-Eberhard HJ. The membrane attack complex of complement [J]. Annu Rev Immunol, 1986, 4: 503-528.
3. Allen TM, Chonn A. Large unilamellar liposomes with low uptake into the reticulo endothelial system [J]. FEBS Lett, 1987, 223: 42-46.
4. Gabizon A, Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors [J]. Proc Natl Acad Sci USA, 1988, 85: 6949-6953.
5. Blume G, Cevc G. Liposomes for the sustained drug release in vivo [J]. Biochim Biophys Acta, 1990, 1029: 91-97. (Pubitemid 20346426)
6. Klibanov AL, Maruyama K, Torchilin VP, et al. Amphipathic polyethyleneglycol effectively prolong the circulation time of liposomes [J]. FEBS Lett, 1990, 268: 235-237. (Pubitemid 20233874)
7. Allen TM, Hansen C, Martin F, et al. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo [J]. Biochim Biophys Acta, 1991, 1066: 29-36.
8. Woodle MC. Surface-modified liposomes: assessment and characterization for increased stability and prolonged blood circulation [J]. Chem Phys Lipids,1993, 64: 249-262. (Pubitemid 23290877)
9. Torchilin VP, Omelyanenko VG, Papisov MI, et al. Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity [J]. Biochim Biophys Acta, 1994, 1195: 11-20. (Pubitemid 24318086)
10. Unezaki S, Maruyama K, Ishida O, et al. Enhanced tumor targeting and improved antitumor activity of doxorubicin by long-circulating liposomes containing amphipathic poly(ethylene glycol) [J]. Int J Pharm, 1995, 126: 41-48. (Pubitemid 26015624)
11. Xu H, Wang KQ, Huang WW, et al. Recent advances in the study of accelerated blood clearance phenomenon of PEGylated liposomes [J]. Acta Pharm Sin, 2010, 45: 677-683.
12. Parr MJ, Ansell SM, Choi LS, et al. Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles [J]. Biochim Biophys Acta, 1994, 1195: 21-30. (Pubitemid 24318087)
13. Kirpotin D, Hong K, Mullah N, et al. Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface-grafted polyethylene glycol) [J]. FEBS Lett, 1996, 388: 115-118. (Pubitemid 26226342)
14. Ishida T, Kirchmeier MJ, Moase EH, et al. Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells [J]. Biochim Biophys Acta, 2001, 1515: 144-158. (Pubitemid 33086831)
15. Xu H, Deng YH, Chen DW. Recent advances in the study of cleavable PEG-lipid derivatives modifying liposomes [J]. Acta Pharm Sin, 2008, 43: 18-22.
16. Xu H, Deng YH, Chen DW, et al. Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives [J]. J Control Release, 2008, 130: 238-245.
17. Xu H. Study on Vesicles/Liposomes Modified with Cleavable PEG-lipid Derivatives (PEG) [D]. Shenyang: Shenyang Pharmaceutical University, 2008: 101-102.
18. Carrion C, Domingo JC, de Madariaga MA. Preparation of long-circulating immunoliposomes using PEG-cholesterol conjugates: effect of the spacer arm between PEG and cholesterol on liposomal characteristics [J]. Chem Phys Lipids, 2001, 113: 97-110. (Pubitemid 33001479)
19. Silvander M, Bergstrand N, Edwards K. Linkage identity is a major factor in determining the effect of PEG-ylated surfactants on permeability of phosphatidylcholine liposomes [J]. Chem Phys Lipids, 2003, 126: 77-83. (Pubitemid 37297967)
20. Yuda T, Maruyama K, Iwatsuru M. Prolongation of liposome circulation time by various derivatives of polyethyleneglycols [J]. Biol Pharm Bull, 1996, 19:1347-1351. (Pubitemid 26363633)
21. Sadzuka Y, Nakade A, Hirama R, et al. Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome [J]. Int J Pharm, 2002, 238: 171-180. (Pubitemid 34457886)
22. Sadzuka Y, Nakade A, Tsuruda T, et al. Study on the characterization of mixed polyethyleneglycol modified liposomes containing doxorubicin [J]. J Control Release, 2003, 91: 271-280. (Pubitemid 36976760)
23. Sadzuka Y, Sugiyama I, Tsuruda T, et al. Characterization and cytotoxicity of mixed polyethyleneglycol modified liposomes containing doxorubicin [J]. Int J Pharm, 2006, 312: 83-89.
24. Bedu-Addo FK, Huang L. Interaction of PEG-phospholipid conjugates with phospholipid: implications in liposomal drug delivery [J]. Adv Drug Deliv Rev, 1995, 16: 235-247.
25. Piperoudi S, Fatouros D, Ioannou PV, et al. Incorporation of PEG-lipids in arsonoliposomes results in formation of highly stable arsenic-containing vesicles [J]. Chem Phys Lipids, 2006, 139: 96-106. (Pubitemid 43183734)
26. Li WM, Xue L, Mayer LD, et al. Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes [J]. Biochim Biophys Acta, 2001, 1513: 193-206. (Pubitemid 32706417)
27. Maruyama K, Yuda T, Okamoto A, et al. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol) [J]. Biochim Biophys Acta, 1992, 1128: 44-49.
28. Ambegia E, Ansell S, Cullis P, et al. Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression [J]. Biochim Biophys Acta, 2005, 1669: 155-163.
29. Judge A, McClintock K, Phelps JR, et al. Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes [J]. Mol Ther, 2006, 13: 328-337. (Pubitemid 43056898)
30. Maruyama K, Takizawa T, Takahashi N, et al. Targeting efficiency of PEG-immunoliposome-conjugated antibodies at PEG terminals [J]. Adv Drug Deliv Rev, 1997, 24: 235-242. (Pubitemid 27112639)
31. Montdargent B, Maillet F, Paule Carreno M, et al. Regulation by sulphonate groups of complement activation induced by hydroxymethyl groups on polystyrene surfaces [J]. Biomaterials, 1993, 14: 203-208. (Pubitemid 23113785)
32. Zalipsky S, Brandeis E, Newman MS, et al. Long circulating, cationic liposomes containing amino-PEG-phosphatidylethanolamine [J]. FEBS Lett, 1994, 353: 71-74. (Pubitemid 24312546)
33. Torchilinl VP, Papisov MI. Why do polyethylene glycolcoated liposomes circulate so long? Molecular mechanism of liposome steric protection with polyethylene glycol: role of polymer chain flexibility [J]. J Liposome Res, 1994, 4: 725-739.
34. Allen C, Dos Santos N, Gallagher R, et al. Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol) [J]. Biosci Rep, 2002, 22: 225-250. (Pubitemid 35222733)
35. Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles [J]. Int J Pharm, 2006, 307: 93-102. (Pubitemid 41773257)
36. Bradley AJ, Devine DV, Ansell SM, et al. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids [J]. Arch Biochem Biophys, 1998, 357: 185-194. (Pubitemid 28419200)
37. Garbuzenko O, Barenholz Y, Priev A. Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer [J]. Chem Phys Lipids, 2005, 135: 117-129. (Pubitemid 40744733)
38. Hristova K, Needham D. The influence of polymer-grafted lipids on the physical properties of lipid bilayers: a theoretical study [J]. J Colloid Interface Sci, 1994, 168: 302-314.
39. Dos Santos N, Allen C, Doppen AM, et al. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding [J]. Biochim Biophys Acta, 2007, 1768: 1367-1377.